Humana Inc. $HUM Shares Sold by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. reduced its position in Humana Inc. (NYSE:HUM) by 16.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 66,125 shares of the insurance provider’s stock after selling 13,098 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Humana were worth $16,937,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of HUM. Montag A & Associates Inc. increased its stake in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the period. CoreCap Advisors LLC increased its stake in Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after buying an additional 37 shares during the period. Rosenberg Matthew Hamilton increased its stake in Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after buying an additional 68 shares during the period. Larson Financial Group LLC increased its stake in Humana by 114.1% in the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after buying an additional 81 shares during the period. Finally, Fulcrum Asset Management LLP acquired a new position in Humana in the 3rd quarter valued at $42,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have issued reports on HUM shares. Jefferies Financial Group raised shares of Humana from a “buy” rating to a “buy” rating in a research note on Wednesday. Cantor Fitzgerald started coverage on shares of Humana in a research note on Wednesday. They issued an “overweight” rating on the stock. Royal Bank Of Canada boosted their price objective on shares of Humana from $189.00 to $246.00 and gave the company a “sector perform” rating in a research note on Thursday, April 30th. Robert W. Baird dropped their price objective on shares of Humana from $264.00 to $205.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Finally, JPMorgan Chase & Co. upped their price target on shares of Humana from $180.00 to $214.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. Nine research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, Humana currently has an average rating of “Hold” and an average price target of $263.35.

Insider Buying and Selling

In other Humana news, insider Sanjay K. Shetty acquired 810 shares of the stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average cost of $185.21 per share, with a total value of $150,020.10. Following the purchase, the insider owned 11,657 shares in the company, valued at approximately $2,158,992.97. The trade was a 7.47% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.20% of the company’s stock.

Humana Price Performance

Shares of NYSE HUM opened at $307.79 on Friday. The stock has a market cap of $36.95 billion, a price-to-earnings ratio of 32.92, a PEG ratio of 2.82 and a beta of 0.68. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $315.66. The company’s 50-day moving average price is $218.13 and its 200 day moving average price is $227.64. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm’s revenue was up 23.5% on a year-over-year basis. During the same period in the prior year, the company earned $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, research analysts forecast that Humana Inc. will post 9.01 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s dividend payout ratio is presently 37.86%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.